The pharmaceutical company Sanofi wants to buy the US vaccine manufacturer Dynavax for a good two billion dollars.
The French company announced on Wednesday that the bid was $15.50 per share in cash. The takeover was unanimously approved by the American board of directors. The purchase is to be paid for from existing cash reserves.
Sanofi shares ended trading at a discount of almost one percent. Dynavax Technologies shares recently jumped almost 40 percent to $15.43.
/he
PARIS (dpa-AFX)
By the way: US stocks can even be traded on finanzen.net ZERO until 11 p.m. (without order fees, plus spreads). Open a depot now for free and secure a new customer bonus!
Selected leverage products on Dynavax Technologies
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Dynavax Technologies
The leverage must be between 2 and 20
Advertising